The Astarta agricultural holding reported a net profit of EUR19.94 million in 2025, which is 4.2 times less than in 2024, according to the company’s annual report on its website.
According to the report, Astarta’s consolidated revenue for the past period decreased by 23% to EUR472 million due to lower oilseed yields, reduced sales volumes of agricultural crops and sugar, combined with lower prices for certain products.
It is noted that export sales of EUR294 million accounted for 62% of consolidated revenue in 2025, while the agricultural segment generated 32% of consolidated revenue, or EUR149 million, which is 28% less than in 2024.
Sugar sales fell by 36% over the past year—to EUR147 million—and accounted for 31% of total revenue. At the same time, the share of soybean processing rose to 24% of Astarta’s revenue, or EUR112 million, thanks to a 6% increase in sales.
Sales in the livestock segment also grew by 6% year-over-year—to EUR56 million, accounting for 12% of total revenue in 2025.
According to the report, Astarta’s gross profit decreased by 42% to EUR137 million due to a EUR46 million decline in the fair value of biological assets and agricultural products, reflecting lower global prices, while EBITDA profit fell by 37% to EUR100 million, while the EBITDA margin decreased by 5 percentage points to 21%.
Astarta noted that its operating cash flow in 2025 decreased 4.5-fold to EUR36 million amid a 16% increase in inventories to EUR186 million, while cash flow from investing activities rose 91% to EUR100 million. Key investments included a strategic upgrade of the agricultural machinery fleet, a soybean processing plant (EUR42 million, with plans to launch in the second half of this year), a new multi-component seed crusher project, and the renovation of dairy farms.
Astarta’s net financial debt in 2025 (excluding lease obligations) stood at EUR94 million as of the end of last year, compared to a positive cash position of EUR21 million in 2024, while net debt doubled year-over-year last year to EUR226 million.
Astarta is a vertically integrated agro-industrial holding operating in eight regions of Ukraine and is the largest sugar producer in Ukraine. It comprises six sugar refineries, agricultural enterprises with a land bank of 220,000 hectares and dairy farms with 22,000 head of cattle, an oil extraction plant in Hlobine (Poltava region), seven grain elevators, and a biogas complex.
Astarta’s net profit for January–September 2025 fell by 42.2% to EUR43.70 million, while consolidated revenue decreased by 22.4% to EUR342.78 million.
Age-sex pyramid of the population of Ukraine for 2024 (thousand people)
The international multi-brand footwear retailer SuperStep will close all of its stores in Ukraine in May and June, according to the Retailers Association of Ukraine (RAU)
Zafer Ozbay, CEO of Eren Retail Group in Ukraine, which manages the Lacoste and SuperStep chains, told RAU that this decision is the result of a strategic analysis of global operations and the structure of sales channels.
“Ukraine remains an important market for us, and this step should be viewed as an optimization of our global operations, not as an indicator of market potential,” Ozbay said.
He clarified that there are no plans to close Lacoste stores and that operations are continuing as usual. According to RAU, as of the end of April, there are 12 Lacoste stores operating in Ukraine: one each in Odesa, Dnipro, and Lviv, and nine in Kyiv.
SuperStep was founded in 2012 in Istanbul and operates in the sport-casual and lifestyle segment, offering a diverse selection of sneakers, accessories, and apparel from world-renowned brands such as Lacoste, Nike, Puma, Adidas, Reebok, New Balance, Tommy Hilfiger, Calvin Klein, and Saucony. The brand entered the Ukrainian market in 2015, opening its first store in the capital’s Sky Mall shopping center; by 2018, it operated five locations: four in the capital and one in Lviv. The chain continued to open stores as part of a full-scale expansion: in 2023 at Victoria Gardens in Lviv, in 2024 at the Dream shopping mall in Kyiv and the Karavan shopping mall in Dnipro, and in 2025, a renovated space opened at the Forum Lviv shopping mall in Lviv.
As of the end of April 2026, six offline locations remained: in the capital’s Lavina Mall and Dream shopping centers, Lviv’s Forum Lviv and Victoria Gardens, Odesa’s Riviera Shopping City, and Karavan Dnipro. The retailer also operates an online store.
Back in March 2026, the Puma brand replaced SuperStep at the Respublika Park shopping center in Kyiv with its new “Field of Play” concept. At the Gulliver shopping center in Kyiv, the New Balance chain is considering SuperStep’s space to open a store with a revamped concept and a larger area—over 300 square meters. Currently, the stores are located next to each other.
JSC “Lekhim” (Kyiv) saw its net profit decline by 65.5% in 2025 compared to 2024, down to 24.424 million UAH.
According to the company’s disclosure in the NSSMC’s information disclosure system, net sales revenue in 2025 increased by 22.2% to UAH 2.191 billion.
JSC “Lekhim” is the holding company of the ‘Lekhim’ group, which includes PJSC “Technolog” (Kyiv region), JSC “Lekhim-Kharkiv,” LLC “Lekhim-Obukhiv” (Kyiv region), UAB “LEKHIM-VILNIUS” (Lithuania), and IP “LEKHIM” (Uzbekistan).
It ranks among the top 10 largest pharmaceutical manufacturers in Ukraine.
The Odessa-based “neighborhood” store chain “Tochka” increased its revenue to 2.7 billion UAH by the end of 2025 and plans to open about 100 more retail locations by the end of 2032, according to the industry publication Retailers.ua.
According to the publication, the chain is demonstrating stable financial performance: while revenue amounted to 2.5 billion UAH in 2023, it declined slightly to 2.3 billion UAH in 2024, but showed growth in 2025. At the same time, the company is growing without taking out loans, relying solely on its own profits, which amounted to 29.8 million UAH in 2025 compared to 33.7 million UAH in 2024.
Currently, the chain has 80 stores in the Odesa and Mykolaiv regions. All of them operate in leased spaces. Plans for 2026 include the launch of seven new stores, specifically in Reni, Okny, and Dachne, as well as the renovation of three existing locations.
“We continue to develop the ‘near home’ format—it is important for us to be close by and convenient for the customer. By the end of 2032, the company plans to launch about 100 more stores and will gradually expand beyond the Odesa region toward central Ukraine,” the retailer’s press service noted.
In its product assortment strategy, the company focuses on everyday essentials, prepared foods, and fresh produce. The chain notes that in some stores, ready-to-eat meals are already outperforming the basic basket in terms of profitability.
“Tochka” also intends to expand its own production and line of private-label products in 2026.
To ensure energy independence, the company has equipped all stores with generators and, starting in the second half of 2025, began installing solar power plants (SPPs) on the roofs of its stores. This allows the company to maintain the operation of refrigeration systems and minimize product write-offs during power outages.
The “Tochka” chain has been on the market since 2012. Its product range includes food and non-food items. The company’s “Bonus Basket” loyalty program offers over 1,000 promotional deals every day.
Pharmaceutical company JSC Galichpharm (Lviv) produced 22.098 million packages of medicines in 2025 and sold finished products worth UAH 1.774 billion.
As the company reported in its financial statements on its website, its net loss in 2025 amounted to UAH 1.151 billion, while at the end of 2024, net profit fell by 39% compared to 2023—to UAH 13.705 million.
As previously reported, the company planned to increase sales by 15% by the end of 2025.
In May 2025, the Commercial Court of Lviv Oblast opened bankruptcy proceedings against the pharmaceutical manufacturer JSC “Galichpharm” based on claims by LLC “Sky-Development” in the amount of UAH 479.262 million. On April 21, 2025, Sky-Development LLC acquired from JSC “Bank ”Finance and Credit“ the rights to claims against JSC ”Galichpharm” under loan agreements and security agreements.
The investment company Sky-Development won an open auction organized by the Deposit Guarantee Fund and acquired the claims of the insolvent JSC Bank Finance and Credit under ten loan agreements with leading Ukrainian pharmaceutical companies: JSC “Galichpharm” and JSC “Kyivmedpreparat.” According to Sky-Development, the total amount of its claims exceeds UAH 3.5 billion.
For their part, Kyivmedpreparat and Galichpharm stated that the information disseminated by Sky Development Investment Company is “unreliable, manipulative, and shows signs of deliberate discrediting of the companies’ activities.” In particular, both companies denied having “multi-billion-hryvnia debts” to “Sky Development.” The pharmaceutical companies viewed the statements by “Sky Development” LLC as “an attempt to illegally and artificially create non-existent creditor debt for a possible future hostile takeover of the companies.”
